focus -WSS

focus

author：hotspot 2025-09-29 01:38:52 - browse：98

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Eyeing GLP

explore

WSS

Study finds gene variants tied to breast cancer risk in Black women

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Study finds gene variants tied to breast cancer risk in Black women

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Bird flu surveillance in wastewater gets boost from consortium

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

knowledge

focus

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Alabama IVF ruling threatens families facing fatal genetic disease

New air purifier tech could be key to improving indoor air quality

He's a Nobel laureate. Critics say he was misleading on Covid

Novavax promises a turnaround & Lilly roils the obesity market

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

New air purifier tech could be key to improving indoor air quality

Why palliative psychiatry is worth discussing

The cancer drug shortage isn’t new — and neither are the solutions

For longer

hotspot

Medicare inequities exacerbate Puerto Rico’s health disparities

Fentanyl is making it harder to start addiction treatment

Alabama IVF ruling threatens families facing fatal genetic disease

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Antivenom research: Lessons from HIV applied in search for universal antidote

Scrutiny of post

leisure time

hotspot

explore

hotspot